Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany; Cardiovascular Research Institute Basel (CRIB), Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
J Crit Care. 2020 Apr;56:100-105. doi: 10.1016/j.jcrc.2019.12.013. Epub 2019 Dec 13.
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is an increasingly used treatment option for patients in need of mechanical cardiopulmonary support, while available outcome data is limited. The aim of this study was to identify predictors for 30-day in-hospital mortality.
We analyzed baseline characteristics and outcomes of 8351 VA-ECMO procedures performed in Germany from 2007 to 2015. Using a multivariable model, we identified the ten most important variables to allow for prediction of 30-day in-hospital mortality. Based on these variables, we created a mortality prediction score (ECMO-ACCEPTS score) to enhance decision making in patients considered for or treated with VA-ECMO support.
Of 8351 patients (71.7% male) 3567 had prior CPR. Mean age was 62 years in the present cohort. The overall 30-day in-hospital mortality was 61%. The ECMO-ACCEPTS score, derived among randomly selected 4175 patients, included ten independent predictors for in-hospital mortality. Internal validation in the remaining 4176 patients confirmed strong differentiation between low and high risk of 30-day in-hospital mortality (r = 0.97 for correlation of predicted with observed mortality, p < .001).
The ECMO-ACCEPTS score might help clinicians to improve risk prediction among VA-ECMO patients for refractory cardiogenic shock.
体外膜肺氧合(VA-ECMO)是一种越来越多地用于需要机械心肺支持的患者的治疗选择,而可用的结果数据有限。本研究的目的是确定 30 天院内死亡率的预测因素。
我们分析了 2007 年至 2015 年在德国进行的 8351 例 VA-ECMO 手术的基线特征和结果。使用多变量模型,我们确定了十个最重要的变量,以允许预测 30 天院内死亡率。基于这些变量,我们创建了一个死亡率预测评分(ECMO-ACCEPTS 评分),以增强对考虑或接受 VA-ECMO 支持的患者的决策。
在 8351 例患者(71.7%为男性)中,3567 例患者有先前的心肺复苏术。本队列的平均年龄为 62 岁。总体 30 天院内死亡率为 61%。ECMO-ACCEPTS 评分是在随机选择的 4175 例患者中得出的,包括 10 个独立的院内死亡率预测因素。在其余 4176 例患者中的内部验证证实了 30 天院内死亡率的低风险和高风险之间的强烈区分(预测死亡率与观察死亡率之间的相关性 r 为 0.97,p <.001)。
ECMO-ACCEPTS 评分可能有助于临床医生提高对难治性心源性休克患者的 VA-ECMO 患者的风险预测。